Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs Clopidogrel in Elderly ACS Patients
NCT01778842Phase 3Unknown
- Start
- Mar 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of prasugrel in acute coronary syndrome (ACS) (2 arms). Primary endpoint: Superiority of prasugrel low dose in Platelet Reactivity at 30 days. Status: unknown.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01778842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01778842.